IRX · ASX

InhaleRx Limited (ASX:IRX)

AU$0.025

 0.0 (0.0%)
ASX:Live
09/05/2025 12:00:00 AM
HALO Ords GROWTH AUS All-Companies
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

IRX Overview

IRX Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Weak

Earnings

Very Strong

Growth

Earnings

Very Strong

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Strong

IRX Price Chart

Key Stats

Market Cap

AU$6.07M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.02 - 0.05

Trade Value (12mth)

AU$492.00

1 week

13.64%

1 month

38.89%

YTD

-24.24%

1 year

-37.5%

All time high

0.42

Key Fundamentals

EPS 3 yr Growth

-13.60%

EBITDA Margin

N/A

Operating Cashflow

$0m

Free Cash Flow Return

-58.40%

ROIC

-191.40%

Interest Coverage

-19.10

Quick Ratio

0.90

Other Data

Shares on Issue (Fully Dilluted)

213m

HALO Sector

Healthcare

Next Company Report Date

N/A

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

IRX Announcements

Latest Announcements

Date Announcements

29 April 25

2025 AGM Notice of Meeting

×

2025 AGM Notice of Meeting

29 April 25

2025 AGM Sample Proxy

×

2025 AGM Sample Proxy

29 April 25

2025 AGM Access Letter

×

2025 AGM Access Letter

28 April 25

Mar25 Quarterly Activities Report

×

Mar25 Quarterly Activities Report

28 April 25

Mar25 Appendix 4C Cash Flow Report

×

Mar25 Appendix 4C Cash Flow Report

24 April 25

IRX Completes First Drawdown Under Clendon Facility

×

IRX Completes First Drawdown Under Clendon Facility

17 April 25

IRX-616a Study Order Executed to Commence Phase 1

×

IRX-616a Study Order Executed to Commence Phase 1

28 March 25

2024 Annual Report

×

2024 Annual Report

28 March 25

2024 Appendix 4G

×

2024 Appendix 4G

28 March 25

2024 Corporate Governance Statement

×

2024 Corporate Governance Statement

14 March 25

Shareholder Town Hall - Webinar Slides

×

Shareholder Town Hall - Webinar Slides

13 March 25

Study Order Executed for Phase 2 BTcP Trial

×

Study Order Executed for Phase 2 BTcP Trial

06 March 25

Town Hall Webinar - 4pm AEDT on 13 Mar 2025

×

Town Hall Webinar - 4pm AEDT on 13 Mar 2025

06 March 25

General Meeting Slides

×

General Meeting Slides

06 March 25

Results of General Meeting

×

Results of General Meeting

03 March 25

Notification of cessation of securities - IRX

×

Notification of cessation of securities - IRX

26 February 25

Preliminary Final Report

×

Preliminary Final Report

06 February 25

Tony Fitzgerald Director Appointment, Director Resignation

×

Tony Fitzgerald Director Appointment, Director Resignation

04 February 25

Notice of General Meeting

×

Notice of General Meeting

04 February 25

General Meeting Sample Proxy Form

×

General Meeting Sample Proxy Form

04 February 25

General Meeting Access Letter

×

General Meeting Access Letter

24 January 25

Updated Dec24 Quarterly Activities Report

×

Updated Dec24 Quarterly Activities Report

23 January 25

Dec24 Quarterly Activities Report

×

Dec24 Quarterly Activities Report

23 January 25

Dec24 Appendix 4C Cash Flow Report

×

Dec24 Appendix 4C Cash Flow Report

19 December 24

Shareholder Update

×

Shareholder Update

17 December 24

Notification of cessation of securities - IRX

×

Notification of cessation of securities - IRX

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

N/A

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

IRX Shortsell

Frequently Asked Questions

The current share price of InhaleRx Limited (IRX:ASX) is AU$0.025.
The 52-week high share price for InhaleRx Limited (IRX:ASX) is AU$0.05.
The 52-week low share price for InhaleRx Limited (IRX:ASX)? is AU$0.02.
InhaleRx Limited (IRX:ASX) does not pay a dividend.
InhaleRx Limited (IRX:ASX) does not pay a dividend.
InhaleRx Limited (IRX:ASX) has a franking level of 0.0%.
InhaleRx Limited (IRX:ASX) is classified in the Healthcare.
The current P/E ratio for InhaleRx Limited (IRX:ASX) is .
logo
Login
Company
Company
Important

Get the latest insights and hot tips delivered right to your inbox

App Store Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.